COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test
Test Name: COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test
Components: COL2A1 gene analysis
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test gene COL2A1
Test Details: The COL2A1 gene is responsible for providing instructions for the production of type II collagen, which is a protein found in connective tissues such as cartilage and the vitreous humor of the eye. Mutations in the COL2A1 gene have been associated with a range of disorders known as type II collagenopathies. Avascular necrosis of the femoral head, also known as osteonecrosis or aseptic necrosis, is a condition characterized by the death of bone tissue in the femoral head due to a lack of blood supply. This can lead to pain, stiffness, and eventually joint collapse. Primary NGS (Next-Generation Sequencing) genetic testing refers to the use of advanced sequencing technologies to analyze multiple genes simultaneously. In the context of avascular necrosis of the femoral head, primary NGS genetic testing can be used to identify mutations or variants in the COL2A1 gene that may be associated with the condition. By analyzing the genetic makeup of an individual using NGS technology, healthcare professionals can identify specific mutations or variants in the COL2A1 gene that may contribute to the development of avascular necrosis of the femoral head. This information can help in diagnosing the condition, understanding its underlying causes, and potentially guiding treatment decisions. It is important to note that avascular necrosis of the femoral head can have various causes, including trauma, steroid use, alcohol abuse, and other genetic factors. Therefore, while genetic testing can provide valuable insights, it is typically used in conjunction with other diagnostic methods to determine the underlying cause of the condition.
Test Name | COL2A1 Gene Avascular necrosis of the femoral head primary Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Avascular necrosis of the femoral head, primary NGS Genetic DNA Test gene COL2A1 |
Test Details |
The COL2A1 gene is responsible for providing instructions for the production of type II collagen, which is a protein found in connective tissues such as cartilage and the vitreous humor of the eye. Mutations in the COL2A1 gene have been associated with a range of disorders known as type II collagenopathies. Avascular necrosis of the femoral head, also known as osteonecrosis or aseptic necrosis, is a condition characterized by the death of bone tissue in the femoral head due to a lack of blood supply. This can lead to pain, stiffness, and eventually joint collapse. Primary NGS (Next-Generation Sequencing) genetic testing refers to the use of advanced sequencing technologies to analyze multiple genes simultaneously. In the context of avascular necrosis of the femoral head, primary NGS genetic testing can be used to identify mutations or variants in the COL2A1 gene that may be associated with the condition. By analyzing the genetic makeup of an individual using NGS technology, healthcare professionals can identify specific mutations or variants in the COL2A1 gene that may contribute to the development of avascular necrosis of the femoral head. This information can help in diagnosing the condition, understanding its underlying causes, and potentially guiding treatment decisions. It is important to note that avascular necrosis of the femoral head can have various causes, including trauma, steroid use, alcohol abuse, and other genetic factors. Therefore, while genetic testing can provide valuable insights, it is typically used in conjunction with other diagnostic methods to determine the underlying cause of the condition. |